We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Dermisonics, a medical device company with its focus on the development of an
ultrasonically assisted transdermal drug-delivery technology, announced that
the U.S. Patent and Trademark Office has issued a notice of allowance for the
approval of the most substantial patent claims for the Medi-Cap, a groundbreaking
transdermal drug-delivery device.
Hansen Medical showcased a new system that combines computed movement with robotic
technology, allowing physicians to control and navigate catheters within the
heart to treat potentially deadly heart-rhythm disorders.
Biophan Technologies, a developer of next-generation medical technology, announced
certain details about its licensing program for making pacemakers and defibrillators
safe for use with magnetic resonance imaging (MRI) systems.
EP MedSystems, a company specializing in electrophysiology
products used in cardiac rhythm management, announced initiation of the landmark
ICE CHIP (Intracardiac Echocardiography guided Cardioversion to Help Interventional
Procedures) multicenter clinical trial.
ELA Medical, a Sorin Group company specializing in the development of cardiac
rhythm management implantable and diagnostic systems, has received FDA clearance
for its new AAIsafeR 2 pacing mode.
Medtronic announced FDA approval and subsequent U.S. launch of the dual-chamber
EnRhythm pacemaker, which promotes natural heart activity by significantly reducing
unnecessary pacing in the heart's right ventricle (lower chamber).
Guidant has received investigational device exemption conditional approval from
the FDA to begin the U.S. portion of its SPIRIT III clinical trial, a large-scale
pivotal clinical trial evaluating the safety and efficacy of Guidant's drug-eluting
stent system for the treatment of coronary artery disease.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused
exclusively on the healthcare industry, announced that it has made an incremental
equity investment in its portfolio company Argon Medical Devices to fund Argon's
strategic acquisition of Clinical Innovations.
Cipher Holding announced that it has successfully acquired a secured convertible
debt position in Positron. Positron is a U.S.-based, publicly traded manufacturer
of positron emission tomography (PET) scanners from IMAGIN Diagnostics Centres,
a Canadian corporation.